ロード中...

Ranibizumab in diabetic macular edema

By 2050 the prevalence of diabetes will more than triple globally, dramatically increasing the societal and financial burden of this disease worldwide. As a consequence of this growth, it is anticipated that there will be a concurrent rise in the numbers of patients with diabetic macular edema (DME)...

詳細記述

保存先:
書誌詳細
主要な著者: Krispel, Claudia, Rodrigues, Murilo, Xin, Xiaoban, Sodhi, Akrit
フォーマット: Artigo
言語:Inglês
出版事項: Baishideng Publishing Group Co., Limited 2013
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3874491/
https://ncbi.nlm.nih.gov/pubmed/24379922
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4239/wjd.v4.i6.310
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!